1. Home
  2. HOUR vs KRRO Comparison

HOUR vs KRRO Comparison

Compare HOUR & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hour Loop Inc.

HOUR

Hour Loop Inc.

HOLD

Current Price

$1.87

Market Cap

72.5M

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$8.18

Market Cap

58.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOUR
KRRO
Founded
2015
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.5M
58.6M
IPO Year
2022
2019

Fundamental Metrics

Financial Performance
Metric
HOUR
KRRO
Price
$1.87
$8.18
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$74.17
AVG Volume (30 Days)
36.2K
244.5K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$140,790,433.00
$7,371,000.00
Revenue This Year
N/A
$144.83
Revenue Next Year
N/A
N/A
P/E Ratio
$76.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$5.20
52 Week High
$6.84
$55.89

Technical Indicators

Market Signals
Indicator
HOUR
KRRO
Relative Strength Index (RSI) 42.02 37.71
Support Level $1.75 $7.73
Resistance Level $1.92 $8.14
Average True Range (ATR) 0.08 0.49
MACD -0.01 0.68
Stochastic Oscillator 33.36 66.15

Price Performance

Historical Comparison
HOUR
KRRO

About HOUR Hour Loop Inc.

Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Share on Social Networks: